Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Jan 15, 2020; 12(1): 1-20
Published online Jan 15, 2020. doi: 10.4251/wjgo.v12.i1.1
Published online Jan 15, 2020. doi: 10.4251/wjgo.v12.i1.1
Organs | Panel tested | Number of genes tested | Number of patients | The type of sample | Companion diagnostic indications | Ref. |
EC | HiSeq2000 | N/A | 144 | Tumor tissue DNA | CCND1, CDKN2A, FBXW7, MLL2, EP300, CREBBP, TET2, NOTCH1, NOTCH3, FAT1, YAP1, AJUBA, PIK3CA, EGFR, ERBB2 | Sawada et al[44], 2016 |
EC | Exiqon miRNA qPCR panel | 168miRNA | 140 | Serum miRNA | miR-20b-5p, miR-28-3p, miR-192-5p, miR-223-3p, and miR-296-5p | Huang et al[50], 2017 |
EC | Ion AmpliSeq Custom DNA Panel | 12 | 27 | Tumor tissue/Serum DNA | BRAF, DDR2, ERBB2, HRAS, KEAP1, KRAS, NFE2L2, NRAS, PIK3CA, PTEN, RHOA | Pasternack et al[112], 2018 |
GC | Illumina HiSeq 2000 | 38 | 138 | Tumor tissue DNA | RHOA, CDH1, PIK3CA, CTNNB1, APC, ARID1A, KMT2C, KRAS | Kakiuchi et al[42], 2014 |
GC | Illumina HiSeq 2000 | N/A | 100 | Tumor tissue DNA | ARID1A, CDH1, MUC6, CTNNA2, GLI3, RNF43, RHOA | Wang et al[43], 2014 |
GC | CANCERPLEX | 435 | 207 | Tumor tissue DNA | ARID1A, CDH1, ERBB2, CCNE1, KRAS | Ichikawa et al[41], 2017 |
GC | Ion-Proton sequencer | 50 | 29 | Tumor tissue DNA | APC, CTNNB, KRAS, NPM1, FBXW7 ERBB2, FGFR2, KIT | Yoshida et al[113], 2019 |
CRC | CANCERPLEX | 415 | 201 | Tumor tissue DNA | ERBB2, APC, CDKN2A, NRAS, ATM, BLM, BRCA2, NBN, NRE11A | Nagahashi et al[39], 2016 |
CRC | IT-PGM seqencing | 22 | 77 | Tumor tissue DNA | RAS, PIK3CA, FBXW7, BRAF, SMAD4, MET, FGFR1 | Capalbo et al [114], 2019 |
CRC | OncoAim™ DNA panel | 39 | 648 | Tumor tissue DNA | KRAS, APC, PIK3CA, SMAD4, BRAF, FBXW7, NRAS | Wang et al[115], 2018 |
CRC | MiSeq | 207 | 22 | Tumor tissue DNA | KRAS, PIK3CA, FBXW7, PTEN, SMAD4, BRAF, CTNNB1, NRAS | Gao et al[116], 2019 |
CRC | cfDNA panel | 14 | 101 | Plasma cfDNA | AKT1, BRAF, CTNNB1, EGFR, ERBB2, FBXW7, GNAS, KRAS, MAP2K1, NRAS, PIK3CA, SMAD4, APC, | Osumi et al, 2018 |
CRC | TruSight Cancer Sequencing Panel | 42 | N/A | Blood ctDNA | MLH1, MSH6, PMS2 APC, SMAD4, TP53, BRIP1, CHEK2, MUTYH, HNF1A, XPC | Seifert et al[117], 2019 |
- Citation: Matsuoka T, Yashiro M. Precision medicine for gastrointestinal cancer: Recent progress and future perspective. World J Gastrointest Oncol 2020; 12(1): 1-20
- URL: https://www.wjgnet.com/1948-5204/full/v12/i1/1.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i1.1